Novartis
Search results
Sandoz is a global leader in generic pharmaceuticals and biosimilars, with a mission to discover new ways to improve and extend people's lives. Learn more about our products, our quality standards, our innovation and sustainability efforts, and our partnerships and collaborations.
- About Sandoz
About Sandoz - Sandoz
- People & Culture
Learn about the people and culture of Sandoz, a global...
- Careers
Careers - Sandoz
- Board of Directors
Meet the board of directors of Sandoz, a global leader in...
- About Sandoz
The company was founded in 1886 by Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928) in Basel (Switzerland) under the name Chemiefirma Kern und Sandoz. Initially the company focused on production of dyes namely alizarin blue and auramine .
<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PVQMF29>m_auth=>m_preview=>m_cookies_win=x" height="0" width="0" style="display:none;visibility ...
At Sandoz, we are committed to making access happen for patients around the world. Our purpose and ambition is to shape the future of medicine by providing high-quality generic and biosimilar medicines at affordable prices. Find out more about our vision, values, and strategy on our website.
Oct 4, 2023 · Novartis announces the planned separation of Sandoz, its Generics and Biosimilars business, into an independent company by way of a 100% spin-off. Find out the latest news, timeline, and details of the spin-off process and the new Sandoz Group AG.
Oct 4, 2023 · Novartis has separated its Generics and Biosimilars business into an independent company, Sandoz, through a dividend-in-kind distribution to shareholders. Novartis reiterates its guidance for FY2023, with sales expected to grow high single digits and core operating income low double digits to mid-teens.
Sandoz is a pharmaceutical company that produces and distributes generic and biosimilar medicines worldwide. Follow Sandoz on LinkedIn to learn about its purpose, mission, values, locations, employees, updates, and more.
